Fluoxetine in Refractory Superior Mesenteric Artery Syndrome by Targeting Comorbid Somatic Symptom Disorder
NCT07115472
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Superior Mesenteric Artery Syndrome
Somatic Symptom Disorder (DSM-5)
Interventions
DRUG:
Fluoxetine
Sponsor
Xijing Hospital of Digestive Diseases